ATE226433T1 - Verbesserte aminosaureloesungen zur behandlung bei peritonealer dialyse - Google Patents

Verbesserte aminosaureloesungen zur behandlung bei peritonealer dialyse

Info

Publication number
ATE226433T1
ATE226433T1 AT94903603T AT94903603T ATE226433T1 AT E226433 T1 ATE226433 T1 AT E226433T1 AT 94903603 T AT94903603 T AT 94903603T AT 94903603 T AT94903603 T AT 94903603T AT E226433 T1 ATE226433 T1 AT E226433T1
Authority
AT
Austria
Prior art keywords
amino acid
peritoneal dialysis
treatment
acid solutions
improved amino
Prior art date
Application number
AT94903603T
Other languages
English (en)
Inventor
Leo Martis
Michael R Jones
Original Assignee
Baxter Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Int filed Critical Baxter Int
Application granted granted Critical
Publication of ATE226433T1 publication Critical patent/ATE226433T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • A61M1/287—Dialysates therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
  • Medicinal Preparation (AREA)
AT94903603T 1992-12-22 1993-12-10 Verbesserte aminosaureloesungen zur behandlung bei peritonealer dialyse ATE226433T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US99585592A 1992-12-22 1992-12-22
PCT/US1993/012077 WO1994014430A1 (en) 1992-12-22 1993-12-10 Improved amino acid solutions for treatment of peritoneal dialysis patients

Publications (1)

Publication Number Publication Date
ATE226433T1 true ATE226433T1 (de) 2002-11-15

Family

ID=25542284

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94903603T ATE226433T1 (de) 1992-12-22 1993-12-10 Verbesserte aminosaureloesungen zur behandlung bei peritonealer dialyse

Country Status (14)

Country Link
US (3) US5670176A (de)
EP (1) EP0626845B1 (de)
JP (1) JP3483885B2 (de)
KR (1) KR100309972B1 (de)
AT (1) ATE226433T1 (de)
AU (1) AU678201B2 (de)
CA (1) CA2129998C (de)
DE (1) DE69332433T2 (de)
DK (1) DK0626845T3 (de)
ES (1) ES2185646T3 (de)
MX (1) MX9308002A (de)
NZ (1) NZ259242A (de)
SG (1) SG48704A1 (de)
WO (1) WO1994014430A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2723690B1 (fr) * 1994-08-17 1996-09-27 Seb Sa Appareil de chauffe pour aliments, en particulier pour la realisation de fritures, comportant une contre-cuve
JPH1171273A (ja) * 1997-08-29 1999-03-16 Terumo Corp 腹膜透析液
DE69839922D1 (de) * 1998-01-05 2008-10-02 Univ Johns Hopkins Diätetische ergänzung für dialyse patienten
US6156797A (en) * 1998-07-07 2000-12-05 Terumo Kabushiki Kaisha Peritoneal dialysis solution
US8105258B2 (en) 1999-04-26 2012-01-31 Baxter International Inc. Citrate anticoagulation system for extracorporeal blood treatments
DE60039978D1 (de) 1999-04-26 2008-10-02 Edwards Lifesciences Ag Substitutions-infusionflüssigkeit und zitratanticoagulation
US7186420B2 (en) * 1999-04-26 2007-03-06 Edwards Lifesciences Corporation Multi-part substitution infusion fluids and matching anticoagulants
US6830692B1 (en) * 1999-09-20 2004-12-14 Degussa Ag Amino acid composition for hemodialysis
US6787039B2 (en) * 2001-01-26 2004-09-07 Degussa Ag Amino acid composition for hemodialysis
JP2002275059A (ja) * 2001-03-15 2002-09-25 Inst Of Physical & Chemical Res 腎機能障害改善用アミノ酸組成物
ITTO20020672A1 (it) * 2002-07-26 2004-01-26 Medestea Res And Production S Composizioni farmaceutiche contenenti cheto-acidi per somministrazione endoperitoneale
US20050148647A1 (en) * 2003-10-31 2005-07-07 Landry Donald W. Hemodialysis solutions and uses thereof
CN100417380C (zh) * 2005-12-14 2008-09-10 于力犁 透析液用氨基酸粉/液、其复合透析液粉/液及制备方法
US20090246250A1 (en) * 2008-03-27 2009-10-01 Affinergy Coating compositions having improved performance
CN102370640A (zh) * 2010-08-18 2012-03-14 俞黎黎 血液透析用复方氨基酸制剂及含复方氨基酸的血液透析用制剂
EP2489408A1 (de) 2011-01-13 2012-08-22 Michael Tchirikov Aminosäurezusammensetzung und deren Verwendung zur Behandlung von fetaler Wachstumsrestriktion (IUGR) und zur parenteralen Ernährung von extrem Frühgeborenen
CN105640947A (zh) * 2014-11-10 2016-06-08 天津金耀集团有限公司 碱性必需氨基酸乳酸盐腹膜透析液药物组合物
CN105640946A (zh) * 2014-11-10 2016-06-08 天津金耀集团有限公司 氨基酸（15）乳酸盐腹膜透析液药物组合物
CN105640948A (zh) * 2014-11-10 2016-06-08 天津金耀集团有限公司 必需氨基酸乳酸盐腹膜透析液药物组合物
CN105640945A (zh) * 2014-11-10 2016-06-08 天津金耀集团有限公司 低钙必需氨基酸腹膜透析液药物组合物
CN105560275A (zh) * 2014-11-10 2016-05-11 天津金耀集团有限公司 碱性低钙必需氨基酸腹膜透析液药物组合物
RU2704032C2 (ru) * 2014-12-04 2019-10-23 Профешинал Дайететикс С.П.А. Композиция на основе аминокислот для восстановления фиброэластина в дермальных соединительных тканях
EP3352586A4 (de) 2015-09-21 2019-05-15 The Board Of Trustees Of The Leland Stanford Junior University Ernährungsbehandlung bei krebserkrankungen
US10342824B2 (en) 2017-07-17 2019-07-09 Dr. Marlowe's Weight Loss Institute, P.L.L.C. Supplement for treating side effects of medications which cause metabolic acidosis
WO2019118519A1 (en) * 2017-12-11 2019-06-20 Filtricine, Inc. Compositions, methods, kits and systems for cancer treatment and metabolic intervention therapy

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0077354A4 (de) * 1981-04-27 1983-09-30 Baxter Travenol Lab Dialyselösung glukose, aminosäuren und insulin enthaltend.
US4357343A (en) * 1981-06-26 1982-11-02 Baxter Travenol Laboratories, Inc. Nutritional composition for management of renal failure
CA1239586A (en) * 1984-10-02 1988-07-26 Dimitrios G. Oreopoulos Dialysis solution containing amino acids
DE3821043A1 (de) * 1988-06-22 1989-12-28 Fresenius Ag Dialysier- und spuel-loesung zur intraperitonealen verabreichung
DE3843289A1 (de) * 1988-12-22 1990-06-28 Diehl Gmbh & Co Treibspiegelmunition
JP3262620B2 (ja) * 1992-02-04 2002-03-04 バクスター・インターナショナル・インコーポレイテッド 腹膜炎によって生ずる傷害および生理学的副作用を最小にするために使用し得る腹膜透析液
US5589197A (en) * 1993-10-04 1996-12-31 Baxter International, Inc. Low sodium peritoneal dialysis solution

Also Published As

Publication number Publication date
KR100309972B1 (ko) 2001-12-28
EP0626845B1 (de) 2002-10-23
EP0626845A1 (de) 1994-12-07
US5698230A (en) 1997-12-16
DE69332433D1 (de) 2002-11-28
AU5748894A (en) 1994-07-19
CA2129998C (en) 2006-07-11
CA2129998A1 (en) 1994-07-07
NZ259242A (en) 1997-03-24
KR950700059A (ko) 1995-01-16
MX9308002A (es) 1994-08-31
ES2185646T3 (es) 2003-05-01
JP3483885B2 (ja) 2004-01-06
US5670176A (en) 1997-09-23
DE69332433T2 (de) 2003-08-14
DK0626845T3 (da) 2003-02-17
SG48704A1 (en) 1998-05-18
US5776503A (en) 1998-07-07
WO1994014430A1 (en) 1994-07-07
JPH07504210A (ja) 1995-05-11
AU678201B2 (en) 1997-05-22

Similar Documents

Publication Publication Date Title
ATE226433T1 (de) Verbesserte aminosaureloesungen zur behandlung bei peritonealer dialyse
EP0207633A3 (en) Sterilant compositions
ATE147981T1 (de) Verabreichung von lamotrigin zur behandlung von neuro-aids
ATE287710T1 (de) Verfahren zum modulieren der mikrozirkulation
ATE311180T1 (de) Verfahren und pharmazeutische zusammensetzung zur verabreichung von eisen an hämodialyse- oder peritonealdialyse-patienten
DE59107536D1 (de) Arzneimittel zur behandlung von hyperlipidämie und/oder atherosklerose
DE69327314D1 (de) Zusammensetzungen enthaltend Lipoprotein-Associated-Coagulation-Inhibitor (LACI) zur Herstellung eines Medikaments zur Behandlung von akuten oder chronischen Enzündungen
ZA959377B (en) A storage stable water solution for infusion containing a thrombin inhibitor
ATE212845T1 (de) Verwendung von cytochrome - p 450 - inhibitoren zur hemmung des stoffwechsels von stickstoffsubstituierten acridinen
DE69511453D1 (de) Verwendung einer Kombination von Antineoplastonen zur Herstellung eines Arzneimittels zur Behandlung der Neurofibromatose
DE69630055D1 (de) Verwendung von olanzapin oder eines salzes für die herstellung eines medikaments für die behandlung von autismus und mentaler retardation
ATE367824T1 (de) Faktor xiii in kombination mit faktor ix zur behandlung von hämophilie b
JPS6466130A (en) High polymer carcinostatic enhancer
UA31672A (uk) Спосіб лікування хворих на сепсис
UA35748A (uk) Спосіб лікування парадонтозу
ES2148057A1 (es) Nuevo uso del diacepam como potenciador del efecto de los inhibidores pde 3
BG94567A (en) Medicaments for the treatment of aids and method for its application
UA15180A (uk) Спосіб коhсервативhого лікуваhhя геhералізоваhого пародоhтиту

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0626845

Country of ref document: EP

REN Ceased due to non-payment of the annual fee